EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

HomeAgenda
Register
Register
Register

PartnershipUpdated on 23 September 2026

Evaluation studies and co-development of mucosal in vitro models

About

Bac3Gel makes 3D mucosa models that reproduce the human mucus layer. We are looking for three kinds of partners in Japan.

Pharmaceutical and biotechnology companies developing live biotherapeutic products, probiotics, or drugs that act at a mucosal surface. We can run an evaluation study on your compound or strain, or build a custom model around your study design.

Food, functional food and nutrition companies that need to evidence gut health effects of probiotic, prebiotic or postbiotic ingredients before clinical work, under conditions closer to the human gut.

Contract research organisations that want to add mucus based 3D models to their service catalogue, under supply or co-development agreements.

Organisation

Bac3Gel, Lda

Company (SME/startup) / 中小企業・スタートアップ

Porto Salvo, Portugal

Similar opportunities